Göttingen, Germany

Gerhard Braus

This inventor holds 1 USPTO granted patent. Top assignee: Rhein Biotech Gesellschaft Fur Neue Biotechnologische Prozesse Und Produkte Mbh. Active years: 2006.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerhard Braus: Innovator in Nucleic Acid Technology

Introduction

Gerhard Braus is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid molecules. His work has implications for the production of polypeptides with chorismate mutase activity, which is essential for various biotechnological applications.

Latest Patents

Gerhard Braus holds a patent for a nucleic acid molecule that codes for a polypeptide with chorismate mutase activity. This invention relates to a nucleic acid molecule that includes derivatives with at least 10% of the chorismate mutase activity. The patent also covers vectors containing these nucleic acid molecules, host cells that comprise them, and their applications in producing polypeptides. Furthermore, the invention discusses methods for creating auxotrophic yeast strains and the use of these strains in recombinant expression of heterologous genes.

Career Highlights

Braus is associated with Rhein Biotech Gesellschaft für Neue Biotechnologische Prozesse und Produkte mbH, where he has been instrumental in advancing biotechnological processes. His innovative work has led to advancements in the production of essential biochemicals, showcasing his expertise in the field.

Collaborations

Throughout his career, Gerhard Braus has collaborated with notable colleagues such as Gerd Gellissen and Ralph H. Pries. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Gerhard Braus is a distinguished inventor whose work in nucleic acid technology has paved the way for advancements in biotechnology. His contributions continue to influence the field and hold promise for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…